The inhibition of human cytomegalovirus (hCMV) protease by hydroxylamine derivatives
- 30 November 1999
- journal article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 9 (21) , 3137-3142
- https://doi.org/10.1016/s0960-894x(99)00539-9
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Inhibition of human cytomegalovirus protease No with monocyclic β-lactamsBioorganic & Medicinal Chemistry Letters, 1998
- Design and synthesis of monocyclic β-lactams as mechanism-based inhibitors of human cytomegalovirus proteaseBioorganic & Medicinal Chemistry Letters, 1998
- Herpesvirus proteases: targets for novel antiviral drugsAntiviral Research, 1997
- Current Therapeutic Challenges in the Treatment of Cytomegalovirus RetinitisJAIDS Journal of Acquired Immune Deficiency Syndromes, 1997
- Novel, selective mechanism-based inhibitors of the herpes proteasesBioorganic & Medicinal Chemistry Letters, 1996
- Structure of the Human Cytomegalovirus Protease Catalytic Domain Reveals a Novel Serine Protease Fold and Catalytic TriadCell, 1996
- Unique fold and active site in cytomegalovirus proteaseNature, 1996
- A new serine-protease fold revealed by the crystal structure of human cytomegalovirus proteaseNature, 1996
- Three-dimensional structure of human cytomegalovirus proteaseNature, 1996
- Assemblin, a herpes virus serine maturational proteinase and new molecular target for antiviralsPerspectives in Drug Discovery and Design, 1995